Cardiomyopathy and other symptomatic heart diseases associated with HIV infection

Current Opinion in Cardiology

Volumn 11, Issue 3, 1996, Pages 325-331

  Herskowitz, Ahvie ^a  

^a Ischemia Research and Education Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIGOXIN; DIURETIC AGENT; PENTAMIDINE; VASODILATOR AGENT;

BACTERIAL ENDOCARDITIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; HEART ARRHYTHMIA; HEART TAMPONADE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SUDDEN DEATH; SURVIVAL TIME;

EID: 0029997893     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199605000-00013     Document Type: Review

References (34)

1. Cohen IS, Anderson DW, Virmani R, Reen BM, Macher AM, Sennesh J, DiLorenzo P, Redfield RR: Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N EnglJ Med 1986, 315:628-630.
2. Hsia J, Ross AM: Pericardial effusion and pericardiocentesis in human immunodeficiency virus infection. Am J Cardiol 1994, 74:94-96. The most comprehensive prospective study to date of pericardial effusions in a cohort composed primarily of homosexual men in an urban Washington, DC, setting.
3. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL: Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993, 71:955-958.
4. Levy WS, Simon G L, Rios JC, Ross AM: Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989, 63:86-89.
5. Kinney EL, Brafman D, Wright RJ: Echocardiographic findings in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). Cathet Cardiovasc Diagn 1989, 16:182-185.
6. Monsuez JJ, Kinney EL, Vittecoq D, Kitzis M, Rozenbaum W, d'Agay F, Wolff M, Marche C, Janier M, Gorin I, Evans J, Autran B: Comparison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease. Am J Cardiol 1988, 62:1311-1313.
7. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H: Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol 1989, 13:1030-1036.
8. Blanchard DG, Hagenhoff C, Chow LC, McCann HA, Dittrich HC: Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV) infected individuals: a serial echocardiographic study. J Am Coll Cardiol 1991, 17:1270-1276.
9. Corallo S, Mutinelli MR, Moroni M, Lazzarin A, Celano V, Repossini A, Baroldi G: Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J 1988, 9:887-892.
10. Akhras F, Dubrey S, Gazzard B and Noble MIM: Emerging patterns of heart disease in HIV infected homosexual subjects with and without opportunistic infections; a prospective colour flow Doppler echocardiographic study. Eur Heart J 1994, 15:68-75. In a prospective echocardiographic study in 124 homosexual men in London followed for an average of 1.6 years, the authors found a 20% incidence of left ventricular dilatation or dysfunction in the subgroup of 101 patients with AIDS. Of these 20 patients, eight had signs and symptoms of congestive heart failure.
11. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA: Heart muscle disease related to HIV infection: prognostic implications. BMJ 1994, 309:1605-1607. A comprehensive description of an observational, prospective echocardiographic study of 296 HIV-positive adults from all major HIV risk groups in Edinburgh, followed for up to 4 years.
12. DeCastro S, d'Amati G, Gallo P, Cartoni D, Santopadre P, Vullo V, Cirelli A, Migliau G: Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol 1994, 24:1018-1024. This prospective, observational, echocardiographic study followed 136 patients from different HIV risk groups, for an average of 1.1 years. Acute, global left ventricular dysfunction occurred in seven patients with AIDS, and six died a primary cardiac death. Histopathologic examination at necropsy in revealed myocarditis or interstitial edema/fibrosis in five patients with cardiomyopathy.
13. Herskowitz A, Willoughby SB, Vlahov D, Baughman KL, Ansari AA: Dilated heart muscle disease associated with HIV infection. Eur Heart J 1995, 16(suppl O):50-55. A review of the clinical features and immunopathogenesis of cardiomyopathy associated with HIV infection in a series of prospectively followed patients and referred patients evaluated at the Johns Hopkins Hospital between December 1988 and June 1993.
14. Anderson DW, Virmani R: Emerging patterns of heart disease in human immunodeficiency virus infection. Hum Pathol 1990, 21:253-257.
15. Herskowitz A, Baughman KL: Effect of HIV infection on the heart. In Heart Disease: Clinical Update. Edited by Braunwald ER. Philadelphia: WB Saunders; 1994:1-10. A comprehensive clinical review of HIV-related heart disease with an emphasis on clinical presentation and etiology.
16. Herskowitz A, Wu T-C, Willoughby SB, Vlahov DA, Ansari AA, Beschorner WE, Baughman KL: Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late stage infection with human immunodeficiency virus. J Am Coll Cardiol 1994, 24:1025-1032. An important study demonstrating that cardiotropic virus infection and myocarditis may be important in the pathogenesis of symptomatic HIV-associated cardiomyopathy. Of 37 patients with left ventricular dysfunction who underwent endomyocardial biopsy, the majority were found to have myocarditis by histology and immunohistology. In situ hybridization studies using antisense riboprobes for HIV-1 and cytomegalovirus immediate early genes yielded specific hybridization within myocytes.
17. Herskowitz A, Willoughby S, Wu T-C, Beschorner WE, Neumann D, Rose NR, Baughman KL, Ansari AA: Immunopathogenesis of HIV-1 associated cardiomyopathy. Clin Immunol Immunopathol 1993, 68:234-241.
18. Wu TC, Pizzomo MC, Hayward GS, Willoughby SB, Neumann DA, Rose NR, Ansari AA, Beschorner WE, Baughman KL, Herskowitz A: In situ detection of human cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS 1992, 6:777-785.
19. Hofman P, Drici M-D, Gibelin P, Michiels, J-F, Thyss A: Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J 1993, 70:376-381.
20. de Bracco MME, Borda E, Galassi N, Perez-Bianco R, Sterin-Borda L: Autoantibodies in HIV-infected patients that modulate the cholinergic activity of heart and gut tissue. Autoimmunity 1993, 14:307-314.
21. Mehta PM, Grainger TA, Lust RM, Movahed A, Terry J, Gilliland MGF, Jolly SR: Effect of cocaine on left ventricular function: relation to increased wall stress and persistence after treatment Circulation 1995, 91:3002-3009.
22. Herskowitz A, Willoughby SB, Baughman KL, Schulman SP, Bartlett JD: Cardiomyopathy associated with anti-retroviral therapy in patients with HIV infection: a report of six cases. Ann Intern Med 1992, 116:311-313.
23. Eisenhauer MD, Eliasson AH, Taylor AJ, Coyne PE, Wortham DC: Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest 1994, 105:389-394. Extensive arrhythmia surveillance was performed prospectively in 14 HIV-infected patients being treated with intravenous pentamidine. An increased risk of torsade de pointes in patients who developed prolonged rate-corrected QT intervals during the first 4 days of therapy.
24. Levy WS, Varghese PJ, Anderson DW, et al.: Myocarditis diagnosed by endomyocardial biopsy in human immunodeficiency virus infection with cardiac dysfunction. Am J Cardiol 1988, 62:658-659.
25. Domanski MJ, Sloas MM, Follmann DA, Scalise PP, Tucker EE, Egan D, Pizzo PA: Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. Pediatrics 1995, 127:137-146. A retrospective study of 137 HIV-infected children who received zidovudine. The relative risk of developing cardiomyopathy was 8.4. Didanosine therapy was not associated with the development of cardiomyopathy. The association between use of antiretroviral therapy with zidovudine and the development of cardiomyopathy is well demonstrated.
26. Flum DR, McGinn, Jr. JT, Tyras DH: The role of the 'pericardial window' in AIDS. Chest 1995, 107:1522-1525. In a retrospective series of 29 patients who underwent pericardial window procedures for pericardial effusions between 1986 and 1994 in urban New York, 24% of cultures were diagnostic, although in 94% of cases there was no change in clinical management based on operative results. At 22 weeks of follow-up, mortality was 100%, indicating a grave prognosis for HIV-related pericardial effusions requiring operative pericardial drainage.
27. Eisenberg MJ, Gordon AS, Schiller NB: HIV-associated pericardial effusions. Chest 1992, 102:956-958.
28. Weiss G, Zangerle R, Wachter H, Fuchs D: Interferon-γ and coronary lesions in HIV infection [letter] Lancet 1993, 341:383.
29. Paton P, Tabib A, Loire R, Tete R: Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993, 144:225-231.
30. Willoughby SB, Vlahov D, Herskowitz A: Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human Immunodeficiency virus seronegative intravenous drug users. Am J Cardiol 1993, 37:108-118.
31. Uva MS, Jebara VA, Fabiani JN, Castel SM, Acar C, Grare P, Dib JC, Deloche A, Carpentier A: Cardiac surgery in patients with human immunodeficiency virus infection: indications and results. J Cardiac Surg 1992, 7:240-243.
32. Ans A, Pomar JL, Saura E: Cardiopulmonary bypass in HIV-positive patients. Ann Thorac Surg 1993, 55:1104-1108.
33. Petitpretz P, Brenot F, Azarian R, Parent F, Rain B, Herve P, Simonneau G: Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation 1994, 89:2722-2727. The most comprehensive study to date examining the clinical characteristics of HIV-associated pulmonary hypertension, this paper supports the view that HIV infection is another common disease state that may be associated with primary pulmonary hypertension. The overall survival rate of HIV-infected patients with pulmonary hypertension is as poor as non-HIV-infected patients with primary pulmonary hypertension.
34. Patel RC, Frishman WH: AIDS and the heart: clinicopathologic assessment Cardiovasc Pathol 1995, 4:173-183. An excellent, comprehensive review of the major forms of AIDS-related heart disease.